Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Strand

Showing results (131-140 of 150) with videos related to

Pageof 15
Sort By:
The Journal of Rheumatology|May 22, 2001
Patient based method of assessing adverse events in clinical trials in rheumatology: the revised Stanford Toxicity IndexV Welch, G Singh, V Strand, et al.
Osteoarthritis and Cartilage|April 20, 2004
OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisitedT Pham, D van der Heijde, R D Altman, et al.
Arthritis and Rheumatism|July 14, 1999
Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritisM E Weinblatt, J M Kremer, J S Coblyn, et al.
Osteoarthritis and Cartilage|April 22, 2006
An integrated analysis of five double-blind, randomized controlled trials evaluating the safety and efficacy of a hyaluronan product for intra-articular injection in osteoarthritis of the kneeV Strand, P G Conaghan, L S Lohmander, et al.
Arthritis and Rheumatism|October 11, 2001
Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator GroupS Cohen, G W Cannon, M Schiff, et al.
Arthritis and Rheumatism|May 1, 1993
Effects of administration of an anti-CD5 plus immunoconjugate in rheumatoid arthritis. Results of two phase II studies. The CD5 Plus Rheumatoid Arthritis Investigators GroupV Strand, P E Lipsky, G W Cannon, et al.
The Journal of Rheumatology|February 11, 1999
Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: consensus on a preliminary core set of outcome domainsJ S Smolen, V Strand, M Cardiel, et al.
Arthritis Research & Therapy|December 12, 2018
Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 studyL C Coates, D D Gladman, P Nash, et al.
Archives of Internal Medicine|November 26, 1999
Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators GroupV Strand, S Cohen, M Schiff, et al.
Annals of the Rheumatic Diseases|November 19, 2008
Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trialJ Smolen, R B Landewé, P Mease, et al.
Pageof 15

Showing results (131-140 of 150) with videos related to

Sort By:
Pageof 15
The Journal of Rheumatology|May 22, 2001
Patient based method of assessing adverse events in clinical trials in rheumatology: the revised Stanford Toxicity IndexV Welch, G Singh, V Strand, et al.
Osteoarthritis and Cartilage|April 20, 2004
OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisitedT Pham, D van der Heijde, R D Altman, et al.
Arthritis and Rheumatism|July 14, 1999
Pharmacokinetics, safety, and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritisM E Weinblatt, J M Kremer, J S Coblyn, et al.
Osteoarthritis and Cartilage|April 22, 2006
An integrated analysis of five double-blind, randomized controlled trials evaluating the safety and efficacy of a hyaluronan product for intra-articular injection in osteoarthritis of the kneeV Strand, P G Conaghan, L S Lohmander, et al.
Arthritis and Rheumatism|October 11, 2001
Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator GroupS Cohen, G W Cannon, M Schiff, et al.
Arthritis and Rheumatism|May 1, 1993
Effects of administration of an anti-CD5 plus immunoconjugate in rheumatoid arthritis. Results of two phase II studies. The CD5 Plus Rheumatoid Arthritis Investigators GroupV Strand, P E Lipsky, G W Cannon, et al.
The Journal of Rheumatology|February 11, 1999
Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: consensus on a preliminary core set of outcome domainsJ S Smolen, V Strand, M Cardiel, et al.
Arthritis Research & Therapy|December 12, 2018
Secukinumab provides sustained PASDAS-defined remission in psoriatic arthritis and improves health-related quality of life in patients achieving remission: 2-year results from the phase III FUTURE 2 studyL C Coates, D D Gladman, P Nash, et al.
Archives of Internal Medicine|November 26, 1999
Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators GroupV Strand, S Cohen, M Schiff, et al.
Annals of the Rheumatic Diseases|November 19, 2008
Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trialJ Smolen, R B Landewé, P Mease, et al.
Pageof 15